Study of Euthyroid Hypothyroxinemia in Metastatic Breast Carcinoma
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Metastatic Breast Cancer|Thyroid Dysfunction
Interventions: DRUG: Triiodothyronine (T3)
Sponsor: Aultman Health Foundation